HFS
RLAY icon

Hughes Financial Services’s Relay Therapeutics RLAY Stock Holding History

Hughes Financial Services’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.57K Sell
84
-3
-3% -$44 ﹤0.01% 818
2026
Q1 		$866 Sell
87
-131
-60% -$1.17K ﹤0.01% 798
2025
Q4 		$1.84K Sell
218
-7
-3% -$50 ﹤0.01% 576
2025
Q3 		$1.39K Hold
225
– – ﹤0.01% 646
2025
Q2 		$794 Sell
225
-83
-27% -$247 ﹤0.01% 764
2025
Q1 		$761 Buy
+308
New +$1.21K ﹤0.01% 751

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Hughes Financial Services's RLAY Position: Q2 2026 in Review

Hughes Financial Services reduced its Relay Therapeutics (RLAY) stake by 3.4% in Q2 2026, selling an estimated $44 and leaving 84 shares worth $1.57K. The position accounts for ﹤0.01% of the portfolio, ranked #818.

Hughes Financial Services first reported a position in RLAY in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.84K in Q4 2025. 259 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Hughes Financial Services held 84 shares of Relay Therapeutics worth $1.57K as of Q2 2026.
  • Hughes Financial Services sold 3 Relay Therapeutics shares in Q2 2026, an estimated $44.
  • Relay Therapeutics made up ﹤0.01% of Hughes Financial Services's portfolio in Q2 2026, its #818 holding.
  • Hughes Financial Services first reported a position in Relay Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • Hughes Financial Services's Relay Therapeutics position peaked at $1.84K in Q4 2025.
  • 259 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Hughes Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.